SKI Market

Indian Indices

Nifty

25,722.10 -155.75
(-0.60%)

Sensex

83,938.71 -465.75
( -0.55%)

Bank Nifty

57,776.35 -254.75
( -0.44%)

Nifty IT

35,712.35 -194.05
( -0.54%)

Global Indices

Nasdaq

47,580.95 37.83
(0.08%)

Dow Jones

6,861.23 17.89
(0.26%)

Hang Seng

52,282.77 957.16
(1.86%)

Nikkei 225

9,715.58 -44.48
(-0.46%)

Forex

USD-INR

88.57 0.35
(0.39%)

EUR-INR

102.67 0.05
(0.05%)

GBP-INR

116.69 0.04
(0.03%)

JPY-INR

0.58 0.00
(-0.51%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Vilin Bio Med Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs

BSE Code

ISIN Demat

Book Value()

78871

INE0L4V01013

16.5329749

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

VILINBIO

165.31

36.9

EPS(TTM)

Face Value()

Div & Yield %

0.16

Back

Manglam Global Corporations reports standalone net profit of Rs 0.02 crore in the June 2025 quarter

Aug 15,2025

Net profit of Manglam Global Corporations reported to Rs 0.02 crore in the quarter ended June 2025 as against net loss of Rs 0.05 crore during the previous quarter ended June 2024. There were no Sales reported in the quarter ended June 2025 and during the previous quarter ended June 2024.

25,722.10 -155.75 (-0.60%)

83,938.71 -465.75 ( -0.55%)

57,776.35 -254.75 ( -0.44%)

35,712.35 -194.05 ( -0.54%)

47,580.95 37.83 (0.08%)

6,861.23 17.89 (0.26%)

52,282.77 957.16 (1.86%)

9,715.58 -44.48 (-0.46%)

88.57 0.35 (0.39%)

102.67 0.05 (0.05%)

116.69 0.04 (0.03%)

0.58 0.00 (-0.51%)